NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

Interesting pivot to Oncovir. That is another mouth to feed for sure. And Advent certainly needs to be fed as well — it might get to a stage that it can feed itself, but doubt that’s the case now.

Crash explained the circumstances well enough as a doctor that might not be familiar with where the company stands in the regulatory process. But I do believe that as long as the company remains mute, there will continue to be a great amount of uncertainty and damage to the share price. And even without rumors, shareholders have found and will find it increasingly difficult to either hold onto their shares or to buy and accumulate additional shares. That’s actually evidenced by low trading volume.

You see DStock, we can have different points of views on management, but still have a meaningful exchange without personal attacks and mischaracterizations of each others perspective.